133 related articles for article (PubMed ID: 25970775)
1. Thioredoxin reductase: a novel, independent prognostic marker in patients with hepatocellular carcinoma.
Li C; Peng Y; Mao B; Qian K
Oncotarget; 2015 Jul; 6(19):17792-804. PubMed ID: 25970775
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.
Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F
Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860
[TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival.
Welling TH; Fu S; Wan S; Zou W; Marrero JA
Cancer Invest; 2012 Dec; 30(10):689-97. PubMed ID: 23072563
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection.
Nishikawa H; Osaki Y; Komekado H; Sakamoto A; Saito S; Nishijima N; Nasu A; Arimoto A; Kita R; Kimura T
Oncol Rep; 2015 Jan; 33(1):88-94. PubMed ID: 25354477
[TBL] [Abstract][Full Text] [Related]
8. Serum thioredoxin reductase is highly increased in mice with hepatocellular carcinoma and its activity is restrained by several mechanisms.
Zhang L; Cheng Q; Zhang L; Wang Y; Merrill GF; Ilani T; Fass D; Arnér ESJ; Zhang J
Free Radic Biol Med; 2016 Oct; 99():426-435. PubMed ID: 27581528
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
Ding Y; Chen B; Wang S; Zhao L; Chen J; Ding Y; Chen L; Luo R
Int J Cancer; 2009 Feb; 124(3):653-8. PubMed ID: 18972435
[TBL] [Abstract][Full Text] [Related]
10. The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma.
Pang Q; Zhang JY; Xu XS; Song SD; Chen W; Zhou YY; Miao RC; Qu K; Liu SS; Dong YF; Liu C
Scand J Clin Lab Invest; 2015 Jan; 75(1):73-84. PubMed ID: 25465804
[TBL] [Abstract][Full Text] [Related]
11. Glyoxylate reductase/hydroxypyruvate reductase: a novel prognostic marker for hepatocellular carcinoma patients after curative resection.
Pan Y; Ni R; Deng Q; Huang X; Zhang Y; Lu C; Li F; Huang D; He S; Chen B
Pathobiology; 2013; 80(3):155-62. PubMed ID: 23486161
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K
Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
14. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment.
Cho HJ; Kim SS; Ahn SJ; Park SY; Park JH; Kim JK; Wang HJ; Cheong JY; Cho SW
Cytokine; 2015 Jun; 73(2):245-52. PubMed ID: 25797190
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
[TBL] [Abstract][Full Text] [Related]
16. The addition of C-reactive protein to validated staging systems improves their prognostic ability in patients with hepatocellular carcinoma.
Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M; Tajiri H
Oncology; 2014; 86(5-6):308-17. PubMed ID: 24924697
[TBL] [Abstract][Full Text] [Related]
17. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells.
Gan L; Yang XL; Liu Q; Xu HB
J Cell Biochem; 2005 Oct; 96(3):653-64. PubMed ID: 16088946
[TBL] [Abstract][Full Text] [Related]
20. DR-70 immunoassay for the surveillance of hepatocellular carcinoma.
Lin SZ; Chen CC; Lee KC; Tseng CW; Lin HY; Chen YC; Lin HC
J Gastroenterol Hepatol; 2012 Mar; 27(3):547-52. PubMed ID: 21883455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
